EXAM 3 Flashcards
What do you add to levodopa to increase the levels of dopamine in the brain?
Carbidopa.
This is a metabolism inhibitor which decreases the amount of levodopa metabolized in the periphery. This leads to an increase of available levodopa to enter the CNS… 10% can enter.
Besides the increase of available levodopa in the CNS, what other benefit is there to taking carbidopa with levodopa?
Since it inhibits its metabolism in the periphery, allowing more to reach the CNS, this also allows for a lower dose of levodopa.
Less in the GI and less in the periphery means less adverse side effects!
- Less N/V
- Not as much orthorstatic hypotension
- Less cardiac effects
What sorts of things should we TEACH about the medications given for Parkinson’s Disease?
- Therapeutic levels are not reached right away.
- The side effects may be pretty bad at first but they will decrease as the therapeutic levels are reached.
- The patient needs to tolerate these adverse side effects until the drug becomes effective… DON’T stop abruptly!
Some patients may develop a tolerance to, or a physical dependence on Parkinson’s drugs.
Do NOT stop abruptly.
Risk of Neuroleptic Malignant Syndrome.
What is the difference between idiopathic Parkinson’s and secondary Parkinson’s disease?
Idiopathic - Michael J. Fox, no known cause.
Secondary - From another cause: Exposure to toxins, side effects of anti-psychotics (pseudo Parkinson)
Ex: Muhammad Ali, got it from repeated blows to the head.
What IS Parkinson’s disease?
A disorder of the extrapyramidal system. (Akathisia.)
Often accompanied by psychological problems such as dementia, depression.
When is the ONSET and what is the TREATMENT?
Onset: middle age. 40-70, peak around 60
Treatment: drugs that balance the neurotransmitters
No cure. Progressive disease.
What is the focus of antiparkinson drugs?
- Restoring dopamine function (by increasing dopamine as well as activation of dopamine receptors).
- Blocking cholinergic activity in the nigrostriatal pathway (by blocking Ach).
What IS the nigrostriatal pathway?!
Nigrostriatal pathway is the efferent connection between the susbtantia nigra and corpus striatum. It is one of the major dopamine pathways in the brain and is particularly involved in the production of movement, as part of a system called the basal ganglia motor loop.
What is Sinemet?
Trade name of combination drug of carbidopa and levodopa.
First line dopamine receptor AGONIST used for treating Parkinson’s Disease symptoms:
pramipexole (Mirapex).
Advantages:
- No toxic metabolites
- No competition for absorption
- Fewer long term failures
Disadvantages:
- More frequent hallucinations (risk increases as pt gets older, so it’s better for younger patients)
- Daytime sleepiness (sleep attacks)
- Orthostatic hypotension (again, less risk with younger)
May be good to add with another parkinson’s medication to help with the fine tremors… or if the pt is experiencing on-off loss of effect.
What are the following symptoms a sign of?
Open-mouthed, drooling
Bradykinesia, loss of balance
Rigid body structure
Parkinson’s Disease
Big concern for falls.
Other signs: tremors, shuffling gait/shortened steps
Tx: Block Ach and/or increase dopamine. There is a fine line of balance between adverse effects and a therapeutic balance.
What is the primary drug to increase dopamine levels?
Levodopa (aka L-dopa)
- 75% of patients experience 50% reduction in symptoms.
- May take several months for the full effect to take place.
This is only a temporary treatment because after about 5 years, the disease will have progressed enough to where this drug will no longer be helpful.
***TEACH not to take with protein = competes with amino acids for intestinal absorption.
Why would selegiline be used for Parkinson’s Disease?
- Has a sublingual form of administration.
2. Helps reduce side effects because does not have to be broken down since it dissolves under the tongue.
How does an increase in dopamine help Parkinson’s Disease?
By increasing the smooth movements. Dopamine is the primary NT for movement.
How does selegiline work?
It’s selective for the B receptors (regarding monoamine oxydase)… inhibits the breakdown of dopamine.
It’s a MAOBi
What is COMT?
Catechol-O-Methyltransferase (COMT) is one of several enzymes that degrade dopamine, epinephrine, and norepinephrine. COMT breaks down dopamine mostly in the part of the brain responsible for higher cognitive or executive function (prefrontal cortex).
This metabolizes the drug to inactive metabolites.
Has to do with levodopa.
What is decarboxylase?
An enzyme that catalyzes the decarboxylation of a particular organic molecule… this metabolizes the drug to dopamine.
Has to do with levodopa.
Psychosis can occur in 20% of patients.
Dyskinesias are more likely to affect the younger patients.
Which drug are these related to?
levodopa.
Also:
- N/V is more common early on but will decrease over time.
- Orthostatic Hypotension is from the peripheral dopamine… so will not be as much of a risk if taken with carbadopa.
- Discoloration of urine, perspiration, saliva. Not harmful, but may stain.
- The increased amt of dopamine in the periphery can lead to cardiac effects… force of contraction, hyper/hypotension.